NDA 018959 · Hospira
Zinc Chloride In Plastic Container
Zinc Chloride · Injection
Priority reviewLast checked: Nov 20, 2026Latest source record: Apr 25, 2024 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1986
Jun 26, 1986
Approved uses
1
Original approval plus efficacy supplements
Registered trials
22
8 Phase 3, 0 recruiting
FAERS reports
25,335
14,263 serious, 1,542 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect May 13, 2026.
INDICATIONS AND USAGE Zinc 1 mg/mL (Zinc Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 26, 1986 Original approval · Type 5 - New Formulation or New Manufacturer · priority review
1 products under this application
- ZINC CHLORIDE IN PLASTIC CONTAINER · ZINC CHLORIDE EQ 1MG ZINC/ML · INJECTABLE, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Zinc Chloride" as an intervention, any sponsor and status, largest first.
- Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With DiabetesEnrolling by invitation
Colgate PalmoliveIndustry
NCT07619729 · 10,000 participants (planned) · Start May 26, 2026 · Primary completion Jan 2, 2028
Drug: Stannous Fluoride Dentifrice; Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash · For: Diabetes Type 2; Periodontal Disease; Caries
Sites: Long Island City, New York
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral CavityPivotal-lookingCompleted
CEL-SCI CorporationIndustry
NCT01265849 · 928 participants · Start Dec 2010 · Primary completion May 15, 2020
Drug: LI; Cyclophosphamide and 2 more · For: Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the Soft Palate
Sites: Springfield, Illinois; Detroit, Michigan; Cincinnati, Ohio · 102 sites in all
- Oral Hygiene Assistance Training ProgramNot yet recruiting
Colgate PalmoliveIndustry
NCT07807397 · 500 participants (planned) · Start Sep 20, 2026 · Primary completion Sep 2027
Drug: Stannous Fluoride Toothpaste (SnF); sodium fluoride 5000 ppm and 3 more · For: Elderly; Periodontal Disease; Gingivitis and 1 more
- The CRISIS Prevention StudyPivotal-lookingTerminated
Michael DeanAcademic, hospital or other
NCT00395161 · 293 participants · Start Apr 2007 · Primary completion Nov 2009
Drug: Metoclopramide; Zinc and 1 more · For: Sepsis
Sites: Little Rock, Arkansas; Los Angeles, California; Washington D.C., District of Columbia · 7 sites in all
- A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival HealthPivotal-lookingCompleted
HALEONIndustry
NCT06602466 · 175 participants · Start Sep 23, 2024 · Primary completion Dec 13, 2024
Drug: Test toothpaste; Colgate Cavity Protection Toothpaste · For: Dental Plaque; Gingivitis
Sites: Birmingham, United Kingdom
- Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical TrialPivotal-lookingCompleted
Semmelweis UniversityAcademic, hospital or other
NCT05178823 · 171 participants · Start Jun 1, 2017 · Primary completion Sep 1, 2019
Drug: Chlorhexidine mouthwash · For: Gingival Diseases; Caries
Sites: Budapest, Hungary
- A Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival HealthPivotal-lookingCompleted
HALEONIndustry
NCT07169188 · 154 participants · Start Sep 9, 2025 · Primary completion Dec 23, 2025
Drug: Test Fluoride Toothpaste; Colgate Cavity Protection Toothpaste · For: Dental Plaque; Gingivitis
Sites: Mississauga, Canada
- Effect of Mouthwash in Reducing the Symptoms Associated With Flu and Cold VirusesPivotal-lookingCompleted
Colgate PalmoliveIndustry
NCT06479226 · 150 participants · Start Jun 5, 2022 · Primary completion Oct 6, 2022
Drug: cetylpyridinium chloride (0.075%) and zinc alcohol free mouthwash · For: Healthy
Sites: Pelotas, Brazil
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- fatigue2,685
- pain2,007
- nausea1,991
- diarrhoea1,922
- headache1,903
- off label use1,871
- drug ineffective1,640
- dyspnoea1,509
- dizziness1,370
- arthralgia1,363
- fall1,278
- asthenia1,265
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 86 |
| 2005 | 100 |
| 2006 | 115 |
| 2007 | 117 |
| 2008 | 144 |
| 2009 | 199 |
| 2010 | 282 |
| 2011 | 284 |
| 2012 | 188 |
| 2013 | 443 |
| 2014 | 591 |
| 2015 | 937 |
| 2016 | 1,063 |
| 2017 | 923 |
| 2018 | 1,056 |
| 2019 | 1,078 |
| 2020 | 1,835 |
| 2021 | 3,033 |
| 2022 | 3,318 |
| 2023 | 2,629 |
| 2024 | 2,494 |
| 2025 | 2,550 |
| 2026 | 1,870 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- A randomised clinical trial to assess maintenance of gingival health by a novel dentifrice containing 0.1%w/w o-cymen-5-ol and 0.6%w/w zinc chloride.
Kakar A, Newby EE, Kakar K, et al. · Int Dent J 2011 · Comparative Study, Randomized Controlled Trial
- Effectiveness of sodium bicarbonate and zinc chloride mouthwashes in the treatment of oral mucositis and quality of life in patients with cancer under chemotherapy.
Mohammadi F, Oshvandi K, Kamallan SR, et al. · Nurs Open 2022 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- The effect of different mouth rinse products on intra-oral halitosis.
Erovic Ademovski S, Lingström P, Renvert S · Int J Dent Hyg 2016 · Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Antibacterial effect of two toothpastes following a single brushing.
Auschill TM, Deimling D, Hellwig E, et al. · Oral Health Prev Dent 2007 · Comparative Study, Randomized Controlled Trial
- In-situ evaluation of barrier-cream performance on human skin using laser-induced breakdown spectroscopy.
Sun Q, Tran M, Smith B, et al. · Contact Dermatitis 2000 · Clinical Trial, Controlled Clinical Trial
- Clinical study of the anticaries efficacy of three fluoride dentifrices containing anticalculus ingredients: three-year (final) results.
Ripa LW, Leske GS, Triol CW, et al. · J Clin Dent 1990 · Clinical Trial, Comparative Study
Sponsor: Pfizer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.